Biomed Peptides Logo
    Back to blog

    CJC-1295 (No DAC) + Ipamorelin Blend: A Provider's Guide to the Combined Vial

    Short answer: The Biomed Peptides lyophilized catalog lists CJC-1295 NO DAC + IPAMORELIN as a combined, two-peptide lyophilized vial in two sizes: 5/5 mg and 10/10 mg. CJC-1295 and ipamorelin are not the same compound. PubChem lists CJC-1295 No DAC as a 29-residue peptide of about 3367.9 g/mol (CID 56841945) and ipamorelin as a five-residue peptide of about 711.9 g/mol (CID 9831659). The blend is supplied to verified licensed providers only.

    This article covers the combined vial as a catalog item. For full identity detail on each peptide, see our CJC-1295 peptide and ipamorelin peptide guides. Clinical decisions stay with the prescribing clinician.

    What is the CJC-1295 + ipamorelin blend?

    It is a single lyophilized vial that contains two separate peptides. The catalog name is CJC-1295 NO DAC + IPAMORELIN. "No DAC" means the CJC-1295 component is the form without the maleimide-lysine Drug Affinity Complex handle. That distinction is explained in our CJC-1295 guide.

    Catalog listings

    Catalog listing Size notation
    CJC-1295 NO DAC + IPAMORELIN 5/5 mg
    CJC-1295 NO DAC + IPAMORELIN 10/10 mg

    The size is written as two numbers because the vial holds two peptides. Read the notation as the labeled amount of each of the two components in the vial. Confirm the exact amounts on the vial label and the lot COA, since the COA is the document that reports what the lot contains.

    Is CJC-1295 the same as ipamorelin?

    No. They are different molecules, and a blend listing doesn't change that. A short identity comparison from public records:

    Attribute CJC-1295 No DAC Ipamorelin
    Length 29 amino acids (amide) 5 amino acids (amide)
    Molecular formula C152H252N44O42 C38H49N9O5
    Molecular weight (PubChem) ≈3367.9 g/mol ≈711.9 g/mol
    PubChem CID 56841945 CID 9831659
    Original description Jetté et al., Endocrinology, 2005 (CJC-1295 as a GRF analog) (DOI) Raun et al., Eur J Endocrinol, 1998 (DOI)

    The mass difference is the practical point for a COA. A combined-vial report should show an identity result for each peptide, one near 3368 Da and one near 712 Da. A report showing only one of them doesn't document the blend.

    How the blend is supplied

    Lyophilized vial format

    The blend ships as a lyophilized powder in a sealed vial. Freeze-drying removes most of the water that drives peptide degradation, so dry vials generally hold up better in storage and transit than solutions (Bachem). Our lyophilized peptides guide covers the format and the clinic workflow.

    Storage on receipt

    • Keep vials sealed, dry, and protected from light. Follow the product label first.
    • Manufacturer guidance says peptides shouldn't be stored in solution because they "may slowly undergo chemical degradation." For longer storage, Bachem recommends keeping them as a lyophilizate in a tightly closed container below −15 °C, with lower temperatures preferred (Bachem).
    • Let a cold vial reach room temperature before you open it so moisture doesn't condense on the powder (Bachem).

    Our lyophilized peptides storage guide covers each step in detail.

    Documentation to request

    Ask for these with every blend lot:

    • Lot-specific COA naming the product, the size (5/5 or 10/10), and the lot
    • Identity for both components, typically mass spectrometry matching about 3367.9 Da for CJC-1295 No DAC (not about 3647 Da for the DAC form) and about 711.9 Da for ipamorelin
    • Amount of each component per vial, plus HPLC purity where reported
    • Endotoxin results where applicable
    • Labeled storage conditions and expiration

    Our peptide COA and third-party testing guide explains how to read each section and match it to the vial in hand.

    CJC-1295 ipamorelin blend: how provider access works

    We supply physician-use product only to licensed healthcare providers, and we don't sell to patients or consumers. Wholesale pricing is visible only to approved accounts.

    1. Submit the provider application.
    2. Our team verifies your credentials, usually within 24–48 hours.
    3. Approved accounts can view pricing, the full lyophilized catalog, and lot documentation.
    4. Order for office use or patient-specific fulfillment, with shipping to all 50 states.

    Request blend documentation for your practice

    Licensed practices and med spas can apply for provider access to view the 5/5 mg and 10/10 mg listings and request lot COAs, or browse the lyophilized catalog to plan their formulary.

    FAQ

    What is the CJC-1295 and ipamorelin blend?

    It is a combined lyophilized vial that contains two separate peptides, CJC-1295 No DAC and ipamorelin. The Biomed Peptides catalog lists it at 5/5 mg and 10/10 mg.

    Is CJC-1295 the same as ipamorelin?

    No. PubChem lists CJC-1295 No DAC as a 29-residue peptide of about 3367.9 g/mol and ipamorelin as a five-residue peptide of about 711.9 g/mol. They are different molecules.

    What does 5/5 mg mean on the blend listing?

    The two numbers reflect the two peptides in the vial. Confirm the labeled amount of each component on the vial label and the lot COA.

    What should a COA for the blend show?

    The product, size, and lot; an identity result for each peptide; the amount of each component; purity; and storage and expiration information.

    Where can a practice buy the blend?

    From a provider-only supplier that verifies licensure. Biomed Peptides supplies it to approved providers. Apply at /apply to see pricing and documentation.

    Sources

    Frequently Asked Questions

    Quick answers related to this article.

    Back to all articles